Updating the Evidence on the Association between Serum Cholesterol and Risk of Late-Life Dementia: Review and Meta-Analysis
Open accessThe DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Abstract
Background: Cohort studies have reported that midlife high total serum cholesterol (TC) is associated with increased risk of Alzheimer’s disease (AD) in late-life but findings have been based on few studies and previous reviews have been limited by a lack of compatible data. Objective: We synthesized all high quality data from cohort studies reporting on the association between total serum cholesterol measured and late-life cognitive outcomes including Alzheimer’s disease (AD), vascular dementia (VaD), any dementia, mild cognitive impairment (MCI), and cognitive decline. Methods: The literature was searched up to October 2016 using a registered protocol. Thirty-four articles meeting study criteria were identified. Seventeen studies published from 1996 to 2014, including 23,338 participants were included in meta-analyses. Results: Relative risk of developing AD for adults with high TC in midlife was 2.14 (95% CI 1.33–3.44) compared with normal cholesterol. Individual studies that could not be pooled also reported high TC in midlife increased the risk of MCI and cognitive decline in late-life. High TC in late-life was not associated with MCI, AD, VaD, any dementia, or cognitive decline. Late-life measured HDL cholesterol and triglycerides were not associated with increased risk of VaD, and HDL was not associated with risk of MCI, AD, or any dementia. There were insufficient data to examine other cholesterol sub-fractions, sex differences, or APOE interactions. Conclusions: Significant gaps in the literature regarding TC and late-life dementia remain. Evidence suggests that high midlife TC increases risk of late-life AD, and may correlate with the onset of AD pathology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Meta-analytic evidence found inconsistent evidence from HICs that high LDL-C in midlife, but not in later life, might be a risk factor for cognitive decline, all cause dementia and AD.”
From Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission (2024) · cites this paper as [151]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“For example, midlife obesity, 105,111,112 hypertension, 85,[105][106][107] prehypertension (systolic blood pressure from 120 to 139 mm Hg or diastolic pressure from 80 to 89 mm Hg) 85 and high cholesterol 113 are associated with an increased risk of dementia in later life.”
From 2023 Alzheimer's disease facts and figures (2023) · cites this paper as [113]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Systematic review evidence has shown there is no consistent evidence linking high cholesterol in midlife or late-life to risk of vascular dementia, and no consistent evidence linking high cholesterol in late-life to risk of AD (5).”
From Oversimplification of Dementia Risk Reduction Messaging Is a Threat to Knowledge Translation in Dementia Prevention Research (2018) · cites this paper as [5]
The cited source says what the claim attributes to it.
In the citing paper
“Systematic review evidence has shown there is no consistent evidence linking high cholesterol in midlife or late-life to risk of vascular dementia, and no consistent evidence linking high cholesterol in late-life to risk of AD (5).”
From Oversimplification of Dementia Risk Reduction Messaging Is a Threat to Knowledge Translation in Dementia Prevention Research (2018) · cites this paper as [5]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552 · cited 1×
“If there was evidence of heterogeneity and four or more studies were available, random effects meta-analysis was used [18, 19].”
MethodQuantifying heterogeneity in a meta‐analysis
Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763 · cited 1×
“Heterogeneity among studies was examined using standard I2 which estimates the proportion of variance due to heterogeneity [16].”
MethodPRISMA-P Group, Moher, D., Shamseer, L., Clarke, M., Ghersi, D., Liberati, A., Petticrew, M., Shekelle, P., & Stewart, L. A. (2015) · Systematic Reviews · doi:10.1186/2046-4053-4-1 · Cited by 26,223 · cited 1×
“MATERIALS AND METHODS Registration of protocol and reporting The review was registered with the International Prospective Register of Systematic Reviews (PROSPERO CRD42015026727) [6] and reported in accordance with the PRISMA checklist [7].”
MethodStang, A. (2010) · European Journal of Epidemiology · doi:10.1007/s10654-010-9491-z · Cited by 17,396 · cited 2×
“Additional quality ratings were conducted for all studies meeting criteria using a checklist adapted from previous reviews, and the Newcastle Ottawa scale [8, 9].”
BackgroundMethodBorenstein, M., Hedges, L. V., Higgins, J. P. T., & Rothstein, H. R. (2009) · doi:10.1002/9780470743386 · Cited by 14,225
Borenstein, M., Hedges, L. V., Higgins, J. P. T., & Rothstein, H. R. (2021) · doi:10.1002/9781119558378 · Cited by 9,799
Winblad, B., Palmer, K., Kivipelto, M., Jelic, V., Fratiglioni, L., Wahlund, L. ‐., Nordberg, A., Bäckman, L., Albert, M., Almkvist, O., et al. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01380.x · Cited by 4,946 · cited 1×
“For clinical diagnosis of MCI, we accepted Petersen [13], Winblad [14], or other widely accepted clinical research criteria.”
MethodCurrent concepts in mild cognitive impairment
Petersen, R. C., Doody, R., Kurz, A., Mohs, R. C., Morris, J. C., Rabins, P. V., Ritchie, K., Rossor, M., Thal, L., & Winblad, B. (2001) · Archives of Neurology · doi:10.1001/archneur.58.12.1985 · Cited by 4,781 · cited 1×
“For clinical diagnosis of MCI, we accepted Petersen [13], Winblad [14], or other widely accepted clinical research criteria.”
MethodHearing loss and cognitive decline in older adults
Lin, F. R., Yaffe, K., Xia, J., Xue, Q.-L., Harris, T. B., Purchase-Helzner, E., Satterfield, S., Ayonayon, H. N., Ferrucci, L., Simonsick, E. M., et al. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.1868 · Cited by 4,017
Kivipelto, M., Helkala, E.-L., Laakso, M. P., Hänninen, T., Hallikainen, M., Alhainen, K., Soininen, H., Tuomilehto, J., & Nissinen, A. (2001) · BMJ · doi:10.1136/bmj.322.7300.1447 · Cited by 1,618 · cited 2×
“However, studies publishing on midlife lacked clear information on the age range of the sample at baseline and the distribution of the sample within midlife and late-life [12, 21].”
Background
Research works printed but not linked: 4
- 2005, Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [updated May 2005]
- Slooter AJC, 2000, Neurology, 54, 2357
- Liao PJ, 2015, Int J Clin Exp Med, 8, 19200
- McGuinness B, 2016, Cochrane Database Syst Rev, 1, CD003160
Cited by
Items 101–200 of 359
Kokura, Y., Kimoto, K., Okada, Y., & 川北, 慎. (2020) · Nutrition · doi:10.1016/j.nut.2020.110889 · Cited by 27
Plant-based dietary patterns and the risk of dementia: a population-based study
de Crom, T. O. E., Steur, M., Ikram, M. K., Ikram, M. A., & Voortman, T. (2023) · Age and Ageing · doi:10.1093/ageing/afad178 · Cited by 27
“The APOE gene is a key regulator of lipid metabolism and the APOE ε4 allele has been linked to an unfavourable lipid profile [33], which has subsequently been linked to an increased risk of dementia [34].”
Causal cardiovascular risk factors for dementia: insights from observational and genetic studies
Kjeldsen, E. W., & Frikke‐Schmidt, R. (2024) · Cardiovascular Research · doi:10.1093/cvr/cvae235 · Cited by 38
Zhang, H., Zhu, W., Niu, T., Wang, Z., An, K., Cao, W., Shi, J., & Wang, S. (2021) · Lipids in Health and Disease · doi:10.1186/s12944-021-01534-5 · Cited by 26
“Hypercholesterolemia is a common risk factor of AD [11, 12] and MCI [13], a stage between normal cognitive function and AD dementia [14].”
BackgroundUmoh, I. O., Reis, H. J., & de Oliveira, A. C. P. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25053044 · Cited by 31
“…cholesterol levels have been associated with cognitive decline and AD development via various pathways and mechanisms like A β accumulation, dysfunction of the BBB, oxidative stress, vascular compromise, neuroin-flammation, tau hyperphosphorylation and brain parenchyma structural changes [144].”
BackgroundEkblad, L. L., Toppala, S., Johansson, J. K., Koskinen, S. V. P., Sundvall, J., Rinne, J. O., Puukka, P. J., Viitanen, M. H., & Jula, A. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170972 · Cited by 28
“Midlife vascular risk factors, such as hypertension [1], dyslipidemia [1, 2], obesity [1], the metabolic syndrome [3], diabetes [4, 5], and insulin resistance even in non-diabetic individuals [6–8] increase the risk for cognitive decline and dementia later in life.”
Bishop, N. J., & Zuniga, K. E. (2019) · Journal of the American College of Nutrition · doi:10.1080/07315724.2019.1566035 · Cited by 25
“Likewise, high saturated fat intake and serum cholesterol levels have been identified as risk factors in the progression of cognitive decline and dementia (45), although evidence of an association between cholesterol intake and cognitive decline is mixed (10).”
BackgroundKang, S., Kim, E., Cho, H., Kim, D. J., Kim, H. C., & Jung, S. J. (2022) · Scientific Reports · doi:10.1038/s41598-022-16788-x · Cited by 34
Dementia Prevention in Clinical Practice
Niotis, K., Akiyoshi, K., Carlton, C., & Isaacson, R. (2022) · Seminars in Neurology · doi:10.1055/s-0042-1759580 · Cited by 28
Nakamura, Y., Kabayama, M., Godai, K., Tseng, W., Akasaka, H., Yamamoto, K. I., Takami, Y., Takeya, Y., Gondo, Y., Yasumoto, S., et al. (2023) · Hypertension Research · doi:10.1038/s41440-023-01271-5 · Cited by 31
“showed no association or a weak association between lipid levels in later life and cognitive decline [16, 17, 19].”
BackgroundDistinct effects of cholesterol profile components on amyloid and vascular burdens
Kang, S. H., Yoo, H., Cheon, B. K., Park, Y. H., Kim, S.-J., Ham, H., Jang, H., Kim, H. J., Oh, K., Koh, S., et al. (2023) · Alzheimer s Research & Therapy · doi:10.1186/s13195-023-01342-2 · Cited by 28
“However, epidemiological evidence of the association between plasma cholesterol levels and dementia is complex [3].”
BackgroundYang, F. N., Stanford, M. J., & Jiang, X. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00057 · Cited by 24
Alanko, V., Gaminde‐Blasco, A., Quintela‐López, T., Loera‐Valencia, R., Solomon, A., Björkhem, I., Cedazo-Mínguez, Á., Maioli, S., Tabacaru, G., Latorre‐Leal, M., et al. (2023) · Glia · doi:10.1002/glia.24348 · Cited by 26
Smith, A. E., Chau, A. C. M., Greaves, D., Keage, H. A. D., & Feuerriegel, D. (2023) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2023.06.004 · Cited by 26
Hypercholesterolemia and the Increased Risk of Vascular Dementia: a Cholesterol Perspective
Shang, G., Shao, Q., Lv, K., Xu, W., Ji, J., Fan, S., Kang, X., Cheng, F., Wang, X., & Wang, Q. (2024) · Current Atherosclerosis Reports · doi:10.1007/s11883-024-01217-3 · Cited by 26
“A series of clinical studies have demonstrated an association between high cholesterol levels in midlife and an increased risk of dementia [15, 16], whereas elevated late-life serum cholesterol may be associated with a reduced risk of VaD [17].”
MacAulay, R. K., Halpin, A., Cohen, A. S., Calamia, M. R., Boeve, A. R., Zhang, L., Brouillette, R., Foil, H. C., Bruce‐Keller, A. J., & Keller, J. N. (2020) · Archives of Clinical Neuropsychology · doi:10.1093/arclin/acaa014 · Cited by 31
Ryan, M. C., Hong, L. E., Hatch, K. S., Gao, S., Chen, S., Haerian, K., Wang, J., Goldwaser, E. L., Du, X. M., Adhikari, B. M., et al. (2022) · Human Brain Mapping · doi:10.1002/hbm.25769 · Cited by 23
The Role of Vascular Risk Factors in Cognitive Impairment and Dementia and Prospects for Prevention
Mahinrad, S., Sorond, F. A., & Gorelick, P. B. (2022) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2022.07.007 · Cited by 25
de Leeuw, F. A., van der Flier, W. M., Tijms, B. M., Scheltens, P., Mendes, V. M., Manadas, B. J., Bierau, J., van Wijk, N., van den Heuvel, E. G. H. M., Mohajeri, M. H., et al. (2020) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2019.12.009 · Cited by 23
Dunk, M. M., Driscoll, I. F., & Initiative, A. D. N. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-215091 · Cited by 29
“However, literature on blood cholesterol and AD is equivocal [26, 37–39] and the mechanisms underlying this relationship remain elusive.”
Moser, E. D., Manemann, S. M., Larson, N. B., Sauver, J. L. S., Takahashi, P. Y., Mielke, M. M., Rocca, W. A., Olson, J. E., Roger, V. L., Remaley, A. T., et al. (2023) · Neurology · doi:10.1212/wnl.0000000000207595 · Cited by 23
“Missing 706 (31) 670 (29) 743 (32) 653 (28) 755 (33)”
Exploring the complexities of 1C metabolism: implications in aging and neurodegenerative diseases
Ghanem, A. B., Hussayni, Y., Kadbey, R., Ratel, Y., Yehya, S., Khouzami, L., Ghadieh, H. E., Kanaan, A., Azar, S. T., & Harb, F. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1322419 · Cited by 28
“However, a recent analysis, based on thirty-four articles linking total serum cholesterol with AD, indicated that there is evidence that suggests that midlife total serum cholesterol increases risk of late-life AD (Anstey et al., 2017).”
BackgroundCardiovascular contributions to dementia: Examining sex differences and female‐specific factors
Alexander, M. W., Paterson, J., Arvanitakis, Z., Black, S. E., Casaletto, K. B., Christakis, M. K., Einstein, G., Galea, L. A. M., Harwood, L., Kirkham, A. A., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70610 · Cited by 29
“66 In 63–65 However, two studies reported such an association in men, butnotinwomen.”
Lefèvre‐Arbogast, S., Wagner, M., Proust‐Lima, C., & Samieri, C. (2019) · Current Nutrition Reports · doi:10.1007/s13668-019-00285-1 · Cited by 23
Rosa, G., Giannotti, C., Martella, L. A., Massa, F., Serafini, G., Pardini, M., Nobili, F. M., & Monacelli, F. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-191075 · Cited by 24
Guo, Y., Li, P., Ma, X., Huang, X., Liu, Z., Ren, X., Yang, Y., Halm‐Lutterodt, N. V., & Yuan, L. (2020) · Current Alzheimer Research · doi:10.2174/1567205017666200810165758 · Cited by 24
The Associations of Dietary Copper With Cognitive Outcomes
Wei, J., Gianattasio, K. Z., Bennett, E. E., Stewart, J. D., Xu, X., Park, E. S., Smith, R. L., Ying, Q., Whitsel, E. A., & Power, M. C. (2022) · American Journal of Epidemiology · doi:10.1093/aje/kwac040 · Cited by 23
Pan, X., Luo, Y., Zhao, D., & Zhang, L. (2022) · BMC Geriatrics · doi:10.1186/s12877-022-03375-y · Cited by 22
Schindler, L. S., Subramaniapillai, S., Barth, C., van der Meer, D., Pedersen, M. L., Kaufmann, T., Maximov, I. I., Linge, J., Leinhard, O. D., Beck, D., et al. (2022) · NeuroImage Clinical · doi:10.1016/j.nicl.2022.103239 · Cited by 32
“Biological markers of obesity, such as lipid profile (Anstey et al., 2017; Reitz, 2012), glucose (Crane et al.”
Liver Health and Dementia in an Italian Older Population: Findings From the Salus in Apulia Study
Lampignano, L., Donghia, R., Griseta, C., Lagravinese, G., Sciarra, S., Zupo, R., Castellana, F., Bortone, I., Guerra, V., Tirelli, S., et al. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.748888 · Cited by 22
“Very long-term cohort follow-ups with AD biomarkers, which the field currently lacks, will be needed to disentangle the impact of lipids on late-life brain health (Anstey et al., 2017).”
BackgroundStatins for secondary prevention and major adverse events after coronary artery bypass grafting
Pan, E., Nielsen, S. J., Mennander, A., Björklund, E., Martinsson, A., Lindgren, M., Hansson, E. C., Pivodic, A., & Jeppsson, A. (2021) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2021.08.088 · Cited by 23
Lin, H., Himali, J. J., Satizabal, C. L., Beiser, A. S., Levy, D., Benjamin, E. J., Gonzales, M. M., Ghosh, S., Vasan, R. S., Seshadri, S., et al. (2022) · Cells · doi:10.3390/cells11091506 · Cited by 20
“A previous study reported an association between elevated levels of high-density lipoprotein cholesterol (HDL-C) and reduced dementia risk (after adjusting for ApoE E4 genotype) [53], although a subsequent meta-analysis failed to detect an association [54].”
BackgroundNday, C. M., Eleftheriadou, D., & Jackson, G. E. (2018) · Journal of Neurochemistry · doi:10.1111/jnc.14256 · Cited by 22
Goodenowe, D. B., & Senanayake, V. K. (2019) · Brain Sciences · doi:10.3390/brainsci9040092 · Cited by 23
“We included HDL-R in our analyses based on the association of HDL-C [39] and TC [40] with AD, and also because of the association of APOE lipoprotein with HDL particles [41].”
MethodMcFarlane, O., Kozakiewicz, M., Kędziora–Kornatowska, K., Gębka, D., Szybalska, A., Szwed, M., & Klich‐Rączka, A. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.590546 · Cited by 20
“, 2004), and that elevated TC in advanced age does not correlate with any form of cognitive decline or dementia (Kivipelto et al., 2001; Beydoun et al., 2011; Anstey et al., 2017).”
BackgroundDo Statins Affect Cognitive Health? A Narrative Review and Critical Analysis of the Evidence
Kazibwe, R., Rikhi, R. R., Mirzai, S., Ashburn, N. P., Schaich, C. L., & Shapiro, M. D. (2024) · Current Atherosclerosis Reports · doi:10.1007/s11883-024-01255-x · Cited by 22
“Midlife hypercholesterolemia, compared to normal cholesterol levels, has been associated with a significantly higher risk of AD, with an estimated HR of 2.14 (95% CI 1.33–3.44) [6].”
InfluentialClinical guidelines «Cognitive disorders in the elderly and senile persons»
Tkacheva, O. N., Yahno, N. N., Незнанов, Н. Г., Шпорт, С. В., Shamalov, N. A., Levin, O. S., Kostyuk, G. P., Gusev, E. I., Martynov, M. Y., Si, G., et al. (2025) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro2025125337 · Cited by 23
Hassen, C. B., Machado‐Fragua, M. D., Landré, B., Fayossé, A., Dumurgier, J., Kivimäki, M., Sabia, S., & Singh‐Manoux, A. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13140 · Cited by 21
“9,10,12 However, it remains unclear if the timing of exposure (before or after 65 years) is more relevant than the length of follow-up and the pathophysiological phase.”
Plasma oxysterols are associated with serum lipids and dementia risk in older women
Dunk, M. M., Rapp, S. R., Hayden, K. M., Espeland, M. A., Casanova, R., Manson, J. E., Shadyab, A. H., Wild, R. A., & Driscoll, I. F. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.13811 · Cited by 22
“3,4 Midlife hypercholesterolemia is associated with heightened AD risk, 5 suggesting that APOE ’s involvement in lipid metabolism may contribute to AD risk.”
BackgroundAung, H. L., Kootar, S., Gates, T. M., Brew, B. J., & Cysique, L. A. (2019) · European Geriatric Medicine · doi:10.1007/s41999-019-00164-6 · Cited by 21
Wang, Y., An, Y., Zhang, D., Yu, H., Zhang, X., Wang, Y., Tao, L., & Xiao, R. (2019) · PubMed · doi:10.1093/jnen/nlz002 · Cited by 21
Perera, G., Rijnbeek, P. R., Alexander, M., Ansell, D., Avillach, P., Duarte‐Salles, T., Gordon, M. F., Lapi, F., Mayer, M. Á., Pasqua, A., et al. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-038753 · Cited by 19
Cipollari, E., Szapary, H. J., Picataggi, A., Billheimer, J. T., Lyssenko, C. A., Ying, G., Shaw, L. M. J., Kling, M. A., Kaddurah‐Daouk, R., Rader, D. J., et al. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-191246 · Cited by 18
“Early epidemiological studies found an association between total serum cholesterol at midlife and late life AD [12], but the most recent, large prospective investigation did not report an association between serum cholesterol and AD [13].”
Bonaterra‐Pastra, A., de Retana, S. F., Rivas-Urbina, A., Puig, N., Benítez, S., Pancorbo, O., Rodríguez‐Luna, D., Pujadas, F., Freijo, M. D. M., Tur, S., et al. (2021) · Biomedicines · doi:10.3390/biomedicines9010072 · Cited by 22
Association of change in cardiovascular risk factors with incident dementia
Sedaghat, S., Lutsey, P. L., Ji, Y., Empana, J. P., Sorond, F. A., Hughes, T. M., Mosley, T. H., Gottesman, R. F., Knopman, D. S., Walker, K. A., et al. (2022) · Alzheimer s & Dementia · doi:10.1002/alz.12818 · Cited by 19
Association between Age at Diagnosis of Hyperlipidemia and Subsequent Risk of Dementia
Pan, Y., Liang, J., Zhang, W., Gao, D., Li, C., Xie, W., & Zheng, F. (2024) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2024.01.029 · Cited by 20
Liu, Y., Chen, M.-T., He, Y., Chen, M., Liang, J.-R., Jia, F., Huang, Q., Zhou, R., & Hou, C. (2024) · Lipids in Health and Disease · doi:10.1186/s12944-024-02285-9 · Cited by 18
Hypertension and Hypercholesterolemia Modify Dementia Risk in Relation to APOE ɛ4 Status
Pillai, J. A., Kou, L., Bena, J., Penn, L., & Leverenz, J. B. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-201609 · Cited by 22
“Hypercholesterolemia has beenreportedasahigh-riskfactorinmidlifemeasure-ments[15,19–23]andstrikinglyaslowriskinlatelife measurementsimpactingdementiaonset[23–25],but thecontributionfrom APOE (cid:2) 4 genotype in these findings is still debated.”
Pharmacists’ Knowledge of Factors Associated with Dementia: The A-to-Z Dementia Knowledge List
Ramos, H., Moreno, L., Gil‐Peinado, M., García‐Lluch, G., Sendra‐Lillo, J., & Alacreu, M. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18199934 · Cited by 20
Pierzchlińska, A., Droździk, M., & Białecka, M. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212198 · Cited by 20
“However, the study population did not include PD cases [32].”
BackgroundOutcome age‐based prediction of successful cognitive aging by total cholesterol
Silverman, J. M., & Schmeidler, J. (2018) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2018.01.009 · Cited by 22
“at midlife, has been associated with bad cognitive outcomes—cognitive decline, dementia, and Alzheimer’s disease (AD) [3,4].”
BackgroundResultInfluentialHao, Y., Li, J., Yue, S., Wang, S., Hu, S., & Li, B. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.917375 · Cited by 19
Wu, B., Liu, Y., Li, H., Zhu, L., Zeng, L., Zhang, Z., & Peng, W. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.391305 · Cited by 24
“A meta-analysis of 17 studies revealed that adults with high total cholesterol in midlife have a higher risk of AD (Anstey et al., 2017).”
MethodKuang, Z.-M. (2020) · Cardiology Research and Practice · doi:10.1155/2020/1484357 · Cited by 22
de Leeuw, F. A., Tijms, B. M., Doorduijn, A. S., Hendriksen, H. M. A., van de Rest, O., de van der Schueren, M. A. E., Visser, M., van den Heuvel, E. G. H. M., van Wijk, N., Bierau, J., et al. (2020) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12120 · Cited by 20
“Hypertension 131 (36) 51 (31) 64 (35) 6 (27) 33 (39) 16 (36) 34 (36) 29 (29)”
MethodInfluentialFeinkohl, I., Winterer, G., & Pischon, T. (2018) · Journal of Epidemiology & Community Health · doi:10.1136/jech-2017-210338 · Cited by 18
King, C. D., & Robinson, R. A. S. (2020) · Analytical Chemistry · doi:10.1021/acs.analchem.9b01974 · Cited by 15
Hope, K. W. (2020) · British Journal of Nursing · doi:10.12968/bjon.2020.29.8.460 · Cited by 19
“…and the risk of late-life dementia, derived from over 23 000 subjects from 17 studies, led to the conclusion that high mid-life total cholesterol increases the risk of late-life Alzheimer’s disease, but the study also acknowledged that significant gaps in the evidence remain (Anstey et al, 2017).”
BackgroundTanner, E. M., Bloom, M. S., Kannan, K., Lynch, J. K., Wang, W., Yucel, R. M., & Fitzgerald, E. F. (2019) · International Journal of Hygiene and Environmental Health · doi:10.1016/j.ijheh.2019.10.012 · Cited by 15
“Smoking, hypertension, obesity, and elevated cholesterol levels during mid-life increase dementia risk, but paradoxically appear to either have no effect or reduce risk in later life (Anstey et al., 2017; Hernán et al., 2008; Pedditizi et al., 2016; Power et al., 2011).”
BackgroundCognitive profile in burning mouth syndrome versus mild cognitive impairment: A comparative study
Femminella, G. D., Canfora, F., Musella, G., Tella, G. S. D., Ugga, L., Pecoraro, G., Leuci, S., Coppola, N., Lucia, N. D., Maldonato, N. M., et al. (2024) · Oral Diseases · doi:10.1111/odi.15087 · Cited by 20
Liu, H., Reynolds, G. P., & Wei, X. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-191111 · Cited by 15
“Elevated cholesterol is a well-established risk factor for cerebrovascular disease including stroke and VaD as it is for cardiovascular disease [14]; the same is reportedly found for AD [15].”
Wei, S., Gao, L., Jiang, Y., Shang, S., Chen, C., Dang, L., Wang, J., Huo, K., Wang, J., & Qu, Q. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00044 · Cited by 18
“, 2014) found a positive correlation, and a meta-analysis (Anstey et al., 2017) also showed that high midlife”
BackgroundResultMendelian Randomization of Dyslipidemia on Cognitive Impairment Among Older Americans
Fu, M., Bakulski, K. M., Tejera, C. H., & Ware, E. B. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.660212 · Cited by 21
“3 In our sample, participants of African ancestry have comparable lipid profiles to those with European ancestry.”
BackgroundRemnant cholesterol and mild cognitive impairment: A cross-sectional study
Zhang, Q., Huang, S., Cao, Y., Dong, G., Chen, Y., Zhu, X., Yun, W., & Zhang, M. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1069076 · Cited by 16
Roy, D., Chakrabarti, S. S., Banerjee, A., Sharma, P., Biswas, A., & Chakrabarti, S. (2019) · Aging Medicine · doi:10.1002/agm2.12068 · Cited by 14
Ihuoma, J., Milan, M., Negri, S., Troyano‐Rodriguez, E., Rudraboina, R., Kosmider, A., Awasthi, S., Csiszar, A., Ungvari, Z. I., Yabluchanskiy, A., et al. (2026) · Redox Biology · doi:10.1016/j.redox.2026.104118 · Cited by 18
Hu, Z., Yuan, Y.-Q., Tong, Z., Liao, M., Yuan, S., Jian, Y., Yang, J.-L., & Liu, W. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03529-y · Cited by 14
“Individuals with hypercholesterolemia during middle and early age are at an elevated risk of developing AD [170], and hypercholesterolemia can exacerbate neurodegeneration [171].”
BackgroundJie, J., Gong, Y., Hu, H., & Liu, S. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05796-2 · Cited by 13
Bonfili, L., Grasselli, F. M., Cuccioloni, M., Cecarini, V., Lufrano, D., Vittadini, E., Galosi, L., Sonsini, G., Ubaldi, M., Turck, J. L., et al. (2025) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2025.109904 · Cited by 19
Midlife predictors of active and healthy aging (AHA) among older businessmen
Urtamo, A., Huohvanainen, E. A., Pitkälä, K. H., & Strandberg, T. E. (2018) · Aging Clinical and Experimental Research · doi:10.1007/s40520-018-1100-0 · Cited by 17
“This finding is consistent with previous studies, which have reported an association between midlife high cholesterol and cognitive decline or dementia in later life [29, 30].”
ResultNaismith, S. L., Leng, Y., Palmer, J. R., & Lucey, B. P. (2022) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12380 · Cited by 14
Different effects of CYP27A1 and CYP7B1 on cognitive function: Two mouse models in comparison
Goikolea, J., Latorre‐Leal, M., Tsagkogianni, C., Pikkupeura, S., Gulyás, B. Z., Cedazo-Mínguez, Á., Loera‐Valencia, R., Björkhem, I., Rodriguez‐Rodriguez, P., & Maioli, S. (2023) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2023.106387 · Cited by 13
Wu, Q., Ailshire, J., Kim, J. K., & Crimmins, E. M. (2024) · The Journals of Gerontology Series A · doi:10.1093/gerona/glae116 · Cited by 14
“Recent meta-analyses do not produce consistent significant associations between late-life TC and cognitive outcomes (18) but suggest that mid-life TC might be a risk factor for late-life dementia (19).”
BackgroundJensen, C. S., Musaeus, C. S., Frikke‐Schmidt, R., Andersen, B. B., Beyer, N., Gottrup, H., Høgh, P., Vestergaard, K., Wermuth, L., Frederiksen, K. S., et al. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00532 · Cited by 13
“However, in late-life, TC was not associated with cognitive or dementia outcomes in any analyses or in any of the large individual studies that were not compatible for pooling (Anstey et al., 2017).”
BackgroundLi, H., Zhou, J., Yue, Z., Feng, L., Luo, Z., Chen, S., Yang, X., & Xiao, B. (2017) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2017.09.016 · Cited by 12
Genetic Interaction with Plasma Lipids on Alzheimer’s Disease in the Framingham Heart Study
Peloso, G. M., Beiser, A., DeStefano, A. L., & Seshadri, S. S. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180751 · Cited by 12
“Epidemiological studies have also pointed to the role of cholesterol and triglycerides in cognitive decline[5] and AD[6, 7] and specifically mid-life cholesterol, where increased total cholesterol is associated with an increased risk of AD[8], although this was not confirmed in other cohorts[9].”
Johnson, N. F., Gold, B. T., Ross, D., Bailey, A. L., Clasey, J. L., Gupta, V. A., Leung, S., & Powell, D. K. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00100 · Cited by 12
“Significant gaps remain in the literature regarding the relationship between non-modifiable variables, such as APOE status, and modifiable lifestyle variables, such as cholesterol (Anstey et al., 2017).”
BackgroundKeage, H. A. D., Feuerriegel, D., Greaves, D., Tregoweth, E., Coussens, S. W., & Smith, A. E. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00643 · Cited by 12
Beyond cardiovascular medicine: potential future uses of icosapent ethyl
Bhatt, D. L., Hull, M. A., Song, M., Hulle, C. V., Carlsson, C. M., Chapman, M. J., & Toth, P. P. (2020) · European Heart Journal Supplements · doi:10.1093/eurheartj/suaa119 · Cited by 14
“Other cardiovascular risk factors, such as high cholesterol levels, have been associated with MCI and AD risk.(97,98) However, the relationship between circulating cholesterol and cholesterol in the brain is complex, and randomized clinical trials of statins have generally failed to show any therapeutic benefit on cog…”
BackgroundChang, H.-T., Chan, P., & Chiu, P. (2024) · BMC Geriatrics · doi:10.1186/s12877-024-05030-0 · Cited by 12
“Previous studies have focused on individuals with normal cognitive states and emphasized the importance of lowering LDL-c on health [46, 47].”
BackgroundChen, X., Wang, B., Sarkar, A., Huang, Z., Ruiz, N. V., Yeung, A. T., Chen, R., & Han, C. (2025) · Science Advances · doi:10.1126/sciadv.adr5448 · Cited by 14
Jeong, S., Lin, L., Pascual‐Leone, Á., & Hsu, Y. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251326107 · Cited by 14
“For instance, midlife obesity, 44 hypertension, 43 and high cholesterol 45 are among the midlife factors associated with an increased risk of dementia in later life.”
Sex-specific lipid dysregulation in the Abca7 knockout mouse brain
Fu, Y., He, Y. Z., Phan, K., Pickford, R., Kim, Y., Dzamko, N. L., Halliday, G. M., & Kim, W. S. (2022) · Brain Communications · doi:10.1093/braincomms/fcac120 · Cited by 14
Fu, J., Huang, Y., Bao, T., Ou, R., Wei, Q., Chen, Y., Yang, J., Chen, X., & Shang, H. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.844066 · Cited by 12
Association of plasma endothelial lipase levels on cognitive impairment
Yun, S., Park, J.-Y., Seo, S. W., & Song, J. (2019) · BMC Psychiatry · doi:10.1186/s12888-019-2174-8 · Cited by 10
Anstey, K. J., & Peters, R. (2018) · The Journal of Prevention of Alzheimer's Disease · doi:10.14283/jpad.2017.27 · Cited by 10
“Systematic review evidence has shown there is no consistent evidence linking high cholesterol in midlife or late-life to risk of vascular dementia, and no consistent evidence linking high cholesterol in late-life to risk of AD (5).”
Self-citationAssociation of major blood lipids with post‐stroke dementia: A community‐based cohort study
Yang, Z., Edwards, D., Burgess, S., Brayne, C., & Mant, J. (2021) · European Journal of Neurology · doi:10.1111/ene.15219 · Cited by 10
Zorkina, Y., Abramova, O. V., Ushakova, V. M., Andreyuk, D., Andriushchenko, N., Ka, P., Savilov, V., Soloveva, K., Kurmishev, M., Syunyakov, T., et al. (2023) · Women & Health · doi:10.1080/03630242.2023.2185750 · Cited by 11
Chen, J., Li, Y., Chen, M., Liu, X., Chen, J., Li, X., Wang, C., Wan, G., & Tian, J. (2023) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202200799 · Cited by 11
Kritz‐Silverstein, D. C., & Bettencourt, R. (2024) · Nutrients · doi:10.3390/nu16162765 · Cited by 12
“According to a review and meta-analysis of seventeen studies, high plasma cholesterol in midlife more than doubles the risk of mild cognitive impairment and Alzheimer’s disease in later years [4].”
MethodMaking DEEP Sense of Lifestyle Risk and Resilience
Kempermann, G. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00171 · Cited by 13
Jeon, Y. J., Jung, S. J., & Kim, H. C. (2020) · European Journal of Neurology · doi:10.1111/ene.14496 · Cited by 11
“Although middle-aged men reportedly have higher cardiovascular and lower cognitive impairment risk than women, previous studies have not conducted gender-specific analyses [1,4].”
BackgroundResultNaringin and Naringenin: Potential Multi-Target Agents for Alzheimer’s Disease
Lu, J., Chen, J., Li, S., Pan, G.-J., Ou, Y., Yuan, L.-F., Jiang, J., Zeng, L., & Zhao, J. J. (2024) · Current Medical Science · doi:10.1007/s11596-024-2921-z · Cited by 9
Yu, L., Liu, W. Y., Liao, C., Shen, N., Liu, A., Cheng, L., & Wang, X. (2025) · The Journal of Prevention of Alzheimer s Disease · doi:10.1016/j.tjpad.2025.100089 · Cited by 9
Gourley, D., Pasha, E. P., Kaur, S., Haley, A. P., & Tanaka, H. (2020) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000392 · Cited by 11
Ponvilawan, B., Charoenngam, N., Rittiphairoj, T., & Ungprasert, P. (2020) · International Journal of Rheumatic Diseases · doi:10.1111/1756-185x.13920 · Cited by 12
Exercise and the Risk of Mild Cognitive Impairment: Does the Effect Depend on Vascular Factors?
Hughes, T. F., Liu, A., Jacobsen, E. P., Rosano, C., Berman, S., Chang, C. H., & Ganguli, M. (2020) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000410 · Cited by 10
Sitting Time, Physical Activity, and Cognitive Impairment in Midlife and Older Adults
Gafni, T., Shuval, K., Weinstein, G., Barlow, C. E., Gabriel, K. P., Willis, B. L., Leonard, D. S., Haskell, W. L., & DeFina, L. F. (2021) · Journal of Aging and Physical Activity · doi:10.1123/japa.2020-0473 · Cited by 12
Ekblad, L. L., Tuisku, J., Koivumäki, M., Helin, S., Rinne, J. O., & Snellman, A. (2023) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x231172519 · Cited by 10
Risk- and protective factors for memory plasticity in aging
Bråthen, A. C. S., de Lange, A. G., Fjell, A. M., & Walhovd, K. B. (2020) · Aging Neuropsychology and Cognition · doi:10.1080/13825585.2020.1727834 · Cited by 12
Metadata
- Authors
- Anstey, K. J., Ashby-Mitchell, K., & Peters, R.
- Affiliations
- Australian National University (AU)
- Corresponding author
- Anstey, Kaarin J.
- Venue
- Journal of Alzheimer’s Disease
- Publisher
- SAGE Publications
- Published
- 2016-11-29
- Volume
- 56
- Issue
- 1
- Pages
- 215-228
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- PMC
- PMC5240556
- OpenAlex
- W2558803774
- Semantic Scholar
- 0c1251803f118cf5e382bfc6624ab0fbd3c53d8f
- Cited by
- 360
- References
- 61
- Citations by year
- 2026: 18 · 2025: 42 · 2024: 52 · 2023: 43 · 2022: 52 · 2021: 51 · 2020: 43 · 2019: 34 · 2018: 18 · 2017: 7
- FWCI
- 2.81
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Alzheimer s Disease (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- UNSWorks (University of New South Wales, Sydney, Australia) (submittedVersion, cc-by-nc-nd)
- ANU Open Research (Australian National University) (submittedVersion, cc-by-nc)
- Funders
- National Institute for Health and Care Research (PDF-2012-05-197)
- National Health and Medical Research Council (1002560)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Keywords
- serum cholesterol
- MeSH terms
- Alzheimer Disease, Cholesterol, Dementia, Humans, Risk Factors, Cohort Studies, Cognitive Dysfunction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
